{
    "clinical_study": {
        "@rank": "38472", 
        "arm_group": [
            {
                "arm_group_label": "DCN01", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Unisol", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "This proof-of-concept study evaluates the clinical efficacy and safety of DCN01 in prepping\n      of the periocular region."
        }, 
        "brief_title": "A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol\u00ae Following Topical Periocular Administration in Healthy Volunteers", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Ocular Infection", 
        "condition_browse": {
            "mesh_term": "Eye Infections"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Have given a written, informed consent\n\n          -  Be willing and able to follow all instructions\n\n          -  A negative urine pregnancy test if female of childbearing potential\n\n        Exclusion Criteria:\n\n          -  Known sensitivities to study medication or its components\n\n          -  Any signs of an active infection\n\n          -  Use of disallowed products during the period indicated prior to the  enrollment or\n             during the study\n\n          -  Be currently pregnant, nursing, or planning a pregnancy; or be a woman that has a\n             positive pregnancy test\n\n          -  Have a condition or a situation which, in the Investigator's opinion, may put the\n             subject at increased risk, confound study data, or interfere significantly with the\n             subject's study participation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01853722", 
            "org_study_id": "13-150-0002"
        }, 
        "intervention": [
            {
                "arm_group_label": "DCN01", 
                "description": "Three serial applications per periocular region.", 
                "intervention_name": "DCN01", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Unisol", 
                "description": "Three serial applications per periocular region.", 
                "intervention_name": "Unisol", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Anti-Infective Agents"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "DCN01", 
            "Ocular Surgical Preparation", 
            "Prophylaxis against infection", 
            "Pre-operative prep"
        ], 
        "lastchanged_date": "May 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Andover", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "01810"
                }, 
                "name": "Andover Eye Associates"
            }, 
            "investigator": {
                "last_name": "Gail L Torkildsen, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol\u00ae Following Topical Periocular Administration in Healthy Volunteers", 
        "other_outcome": {
            "measure": "Adverse Events (reported, elicited, observed)", 
            "safety_issue": "Yes", 
            "time_frame": "Post dose and up to 2 weeks after (Day 1-14)"
        }, 
        "overall_contact": {
            "last_name": "Sunita Saigal", 
            "phone": "978-685-8900"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in periocular region bacterial load", 
            "safety_issue": "No", 
            "time_frame": "Baseline to 10 min post dose"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01853722"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Proportion of periocular regions with a reduction from baseline in bacterial load.", 
            "safety_issue": "No", 
            "time_frame": "Baseline to 10 min post dose"
        }, 
        "source": "Deacon Biosciences, Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "ORA, Inc.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Deacon Biosciences, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}